Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Understanding when to seek financial planning advice is essential for achieving your goals. Be informed and make wise choices.
19,165 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
The Ethereum Foundation lays out a 2026 roadmap centered on post-quantum security and bigger gas limits, reorganizing...
Rumors swirl about a SpaceX IPO and what it means for space equities. This guide breaks down the potential good, bad,...
Looking for a few durable holdings to anchor a decades-long portfolio? Here are three monster stocks hold next—giants...
A wave of fresh analyst upgrades and price-target bumps hits NVIDIA, Alphabet, and other big names as markets start t...
As Elanco maps out its path for 2025, investors weigh growth drivers, margins, and catalysts. This guide breaks down ...
In 2025, rare earths drew intense attention as prices and equities raced higher. The rally cooled quickly, leaving in...
Dorman's 2025 earnings narrative hinges on aftermarket demand, margins, and strategic bets. This guide breaks down wh...
President Trump directed federal agencies to end Anthropic's AI use, with a six-month phaseout for the Pentagon as a ...
Anthropic's Claude outage on March 2, 2026 disrupted AI workflows for thousands of developers and enterprise customer...
BigBear.ai has emerged as a key name in enterprise AI and decision intelligence. This guide breaks down bigbear.ai (b...
As 2026 unfolds, a fresh wave of growth stocks could power bigger gains for patient investors. This article highlight...